-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$10.6719.22% Upside
Corvus Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Corvus Pharmaceuticals, Inc.?
Corvus Pharmaceuticals, Inc. has been rated by research analysts at Jefferies, Mizuho Securities, Oppenheimer in the past 90 days.